ArticleImmunologic research2026
Expression of key genes in IVIG-unresponsive Kawasaki disease and their immune correlation based on bioinformatics analysis.
Article in Immunologic research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
This study employed bioinformatics to analyze the gene expression profile of Kawasaki disease (KD) patients and identify key genes associated with intravenous immunoglobulin (IVIG) non-response. The aim was to elucidate the pathogenesis of IVIG non-responsive KD and identify potential predictive biomarkers and therapeutic targets. Gene expression datasets GSE48498 and GSE16797 were analyzed. Key steps included differential expression analysis, functional enrichment (GO/KEGG), weighted gene co-expression network analysis (WGCNA), immune cell infiltration analysis (CIBERSORT), protein-protein interaction (PPI) network construction, and machine learning algorithms (LASSO regression and random forest). Findings were validated using RT-qPCR. Differential expression analysis identified 327 differentially expressed genes (DEGs), enriched primarily in immune-related pathways. WGCNA revealed that the cyan and yellow modules exhibited a positive correlation with neutrophil and M0 macrophage infiltration levels. Integration of PPI networks, least absolute shrinkage and selection operator (LASSO) regression, and random forest algorithms identified CXCR1, FPR2, and MMP25 as core genes. Receiver operating characteristic (ROC) analysis yielded area under the curve (AUC) values of 0.887, 0.869, and 0.869 for CXCR1, FPR2, and MMP25, respectively; the combined diagnostic efficacy reached an AUC of 0.905. RT-qPCR validation confirmed significantly higher expression levels of CXCR1 and FPR2 in the IVIG non-responder group compared to responders (P < 0.05), while MMP25 expression showed no significant difference between groups. This study, combining bioinformatics analysis with experimental validation, identifies CXCR1 and FPR2 as key genes implicated in IVIG non-responsive KD.
Indexed as
Identifiers
41575683What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.